logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2016.06.29 2014가합19528
사해행위취소
Text

1. All of the plaintiffs' claims are dismissed.

2. The costs of lawsuit are assessed against the plaintiffs.

Reasons

1. Basic facts

A. The Plaintiffs are pharmaceutical companies that sell and manufacture drugs. The Defendant is a company that operates cyber-mall as an electronic commerce-related company and arranges the manufacture of drugs or transactions between pharmaceutical wholesalers and pharmacies by operating the cyber-mall as an electronic commerce-related company.

B. The Plaintiffs and A Co., Ltd. (hereinafter “A”) are drug wholesalers.

(2) The sum of the supply prices not received from A by February 2014 is KRW 756,715,242.

3) The aggregate amount of the supply price that was not received from A by February 2014 was KRW 214,46,318 among the supply price of KRW 180,00,00,000, which was not paid by the Plaintiff Yang C by February 2, 2014, is KRW 34,466,618; and thus, the unpaid supply price is KRW 34,46,618; 4) The aggregate amount of the supply price that was not paid by the Plaintiff Yang C by January 2014 is KRW 114,361,335, and KRW 47,938,697 was returned and processed, and KRW 30,00,00 was appropriated by the execution of security and the unpaid supply price is KRW 36,422,638.

C. The Defendant and A entered into a business partnership agreement with the Defendant from April 1, 201 to February 2014, and the Defendant and A entered into an electronic commerce transaction with the Defendant through the Defendant, and around February 1, 2013, A kept drugs in the logistics warehouse owned by the Defendant (hereinafter “instant warehouse”).

1) The defendant is a corporation of Mail medicine Co., Ltd. (hereinafter referred to as "Mail medicine").

(2) The Defendant, around July 2013, is in custody in the warehouse of this case in order to secure the claim for indemnity against the sexual medicine. The Defendant is in custody in the warehouse of this case, in order to secure the claim for indemnity against the sexual medicine.

arrow